|Articles|January 30, 2006

FDA panel wants to ban certain OTC asthma inhalers

An FDA advisory panel has voted 11-7 to recommend that the FDA ban certain nonprescription inhalers because they contain propellants that harm the ozone layer. Among the products that would be affected by a ban is Wyeth Consumer Healthcare's Primatene Mist.

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Latest CME

On-Demand Webinar

Navigating Adverse Effects in HR+/HER2-Negative Metastatic Breast Cancer: Tailored Management Plans and Pharmacist Interventions for Improved Outcomes

1.0 Credits / Breast Cancer, Oncology, Women's Health

On-Demand Webinar

Bridging Knowledge Gaps in HR+/HER2– Early-Stage Breast Cancer

0.75 Credits / Breast Cancer, Oncology, Women's Health

On-Demand Webinar

Optimizing Therapy in HR+/HER2-Negative Metastatic Breast Cancer: Navigating Novel Treatments and Personalized Care

1.0 Credits / Breast Cancer, Oncology, Women's Health

On-Demand Webinar

Optimizing HER2-Directed Therapy in Metastatic Breast Cancer: From HER2-Positive to HER2-Ultralow

1.5 Credit / Breast Cancer, Oncology, Women's Health

On-Demand Webinar

Shaping the Future of Generalized Myasthenia Gravis Management: A Focus on Novel Treatment Approaches

1.0 Credits / Neurology

On-Demand Webinar

Expert Insights on the Horizon of HER2-Directed Therapy

0.5 Credit / Breast Cancer, Oncology, Women's Health

On-Demand Virtual Symposium

Breaking Barriers in Asthma Care: Exploring the Role of Type 2 Inflammation and Biologic Therapies

1.5 Credit / Immunology, Pulmonology/Respiratory

On-Demand Virtual Symposium

Type 2 Inflammation in Focus: Advancing Pediatric Atopic Dermatitis Care With Biologic Therapies

1.5 Credits / Dermatology, Immunology

On-Demand Virtual Symposium

From Flares to Freedom: Navigating the Journey of Patients With Chronic Spontaneous Urticaria With Next-Generation Therapies

1.5 Credits / Immunology

On-Demand Virtual Symposium

Chronic Obstructive Pulmonary Disease and Inflammation: Practical Approaches to Integrating Biologic Therapy

1.5 Credits / Immunology, Pulmonology/Respiratory

On-Demand Virtual Symposium

Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases

1.0 Credit

Online Article

Innovations in Lymphoma Treatment and the Growing Impact of Bispecific Antibodies

2.0 Credits / Hematologic Cancer, Oncology

On-Demand Panel Discussion

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

1.5 Credit / Hematology, Rare Diseases

Online Article

Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC

2.0 Credits / Lung Cancer, Oncology, Pulmonology/Respiratory

Online Article

Payment for Pharmacist Services: 2025 Update

1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law

On-Demand Webinar

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

1.0 Credit / Immunology, Rare Diseases

On-Demand Webinar

The Oncology Pharmacist's Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enhance Patient-Centered Care

1.0 Credit / Oncology

On-Demand Webinar

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

1.0 Credit / Nephrology

On-Demand Webinar

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

1.75 Credit / Hematologic Cancer, Hematology, Oncology

On-Demand Webinar

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

1.0 Credits / Dermatology, Immunology

Online Article

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

2.0 Credits / Immunology, Rare Diseases, Hematology

On-Demand Webinar

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

1.0 Credit / Immunology, Neurology, Rare Diseases

$Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists$

On-Demand Webinar

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

1.25 Credits / Hematologic Cancer, Oncology

On-Demand Webinar

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

1.0 Credits / Hematologic Cancer, Oncology, Hematology

FDA panel wants to ban certain OTC asthma inhalers

Related Content

ASHP Adopts New Policies Around Misinformation and Vaccine Access Gaps

Once Weekly Oral HIV Regimen Maintains Suppression Through Week 48

Effective Medication Alert Systems Require Optimization for Improvement

Q&A: Improving Pain Management Requires Strong Leadership, Robust Data

Pharmacy Law Lowdown: Copay Collection Compliance

Latest CME

Navigating Adverse Effects in HR+/HER2-Negative Metastatic Breast Cancer: Tailored Management Plans and Pharmacist Interventions for Improved Outcomes

Bridging Knowledge Gaps in HR+/HER2– Early-Stage Breast Cancer

Optimizing Therapy in HR+/HER2-Negative Metastatic Breast Cancer: Navigating Novel Treatments and Personalized Care

Optimizing HER2-Directed Therapy in Metastatic Breast Cancer: From HER2-Positive to HER2-Ultralow

Shaping the Future of Generalized Myasthenia Gravis Management: A Focus on Novel Treatment Approaches

Expert Insights on the Horizon of HER2-Directed Therapy

Breaking Barriers in Asthma Care: Exploring the Role of Type 2 Inflammation and Biologic Therapies

Type 2 Inflammation in Focus: Advancing Pediatric Atopic Dermatitis Care With Biologic Therapies

From Flares to Freedom: Navigating the Journey of Patients With Chronic Spontaneous Urticaria With Next-Generation Therapies

Chronic Obstructive Pulmonary Disease and Inflammation: Practical Approaches to Integrating Biologic Therapy

Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases

Innovations in Lymphoma Treatment and the Growing Impact of Bispecific Antibodies

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC

Payment for Pharmacist Services: 2025 Update

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

The Oncology Pharmacist's Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enhance Patient-Centered Care

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

Trending on Drug Topics

Once Weekly Oral HIV Regimen Maintains Suppression Through Week 48

New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages

ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain

Postpartum Mothers Favor Bedtime Stopping Rule Over Stricter Chrononutrition Approaches

What’s Next for Pneumococcal Vaccination? An Expert Weighs In